MANCHESTER, UK – 31 March, 2009 – RainDance Technologies, Inc. will present a session on sequence enrichment using innovative microdroplet-based solutions at the “Genomics in Business” conference in Amsterdam on 20 April, 2009. Recent advances in DNA sequencing technologies have impro
Delivery to Ontario Institute for Cancer Research LEXINGTON, MASSACHUSETTS, U.S.A., March 26, 2009 — RainDance Technologies, Inc., a provider of innovative microdroplet-based solutions for human health and disease research, today announced the first commercial shipment of its RD
Detection and analysis of low-abundance cell-surface biomarkers using enzymatic amplification in microfluidic droplets H.N. Joensson, M.L. Samuels, E.R. Brouzes, M. Medkova, M. Uhlen, D.R. Link, H. Andersson-Svahn, Angew. Chem. Int. Ed, 48, 2518 (2009).
BOSTON, MASSACHUSETTS, U.S.A., March 17, 2009 — RainDance Technologies, Inc., a privately held provider of innovative microdroplet-based solutions for human health and disease research, today announced it will be shipping its first commercial Sequence Enrichment Solution this month an
RainDance Technologies® is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as the ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and the ThunderStorm System winning the award in 2011.